Cherie L Stabler Selected Research

Cherie L Stabler Research Topics

15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021 - 01/2008
5	Hypoxia (Hypoxemia) 01/2021 - 03/2012
4	Inflammation (Inflammations) 01/2017 - 01/2008
3	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 01/2008
1	Diabetes Complications 01/2020
1	Foreign-Body Reaction 01/2019

5	Insulin (Novolin)FDA Link 01/2021 - 12/2013
4	Biocompatible Materials (Biomaterials)IBA 10/2021 - 03/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2012
3	Oxygen (Dioxygen)IBA 01/2021 - 03/2012
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 09/2010
2	serum P-component (CIt)IBA 07/2014 - 09/2010
1	AutoantigensIBA 10/2021
1	Isoantigens (Alloantigen)IBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	N-Formylmethionine (Formylmethionine, N)IBA 01/2017
1	Sorbitol (Yal)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	CytokinesIBA 01/2017
1	CitrullineIBA 01/2017
1	Kynurenic Acid (Kynurenate)IBA 01/2017
1	KynurenineIBA 01/2017
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2017
1	GlucocorticoidsIBA 08/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2015
1	Pharmaceutical PreparationsIBA 07/2014

10	Islets of Langerhans Transplantation 10/2021 - 09/2010
5	Therapeutics 12/2021 - 12/2013
4	Transplantation 01/2020 - 01/2008
2	Glycemic Control 01/2020 - 01/2008
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021